Histopathologic Manifestations of Immune Checkpoint Inhibitor Therapy-Associated Gastrointestinal Tract Injury: A Practical Review

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)703-718
Number of pages16
JournalSurgical Pathology Clinics
Volume16
Issue number4
DOIs
StatePublished - Dec 2023

Keywords

  • Cytotoxic T lymphocyte antigen (CTLA)-4
  • Immune checkpoint inhibitors
  • Immune-related adverse events
  • Programmed death (PD)-1
  • Programmed death ligand (PD-L1)

ASJC Scopus subject areas

  • Surgery
  • Pathology and Forensic Medicine

Cite this